Home / Inspections / 1312826

FDA Inspection 1312826 — Icahn School of Medicine at Mount Sinai IRB

Icahn School of Medicine at Mount Sinai IRB — FEI 2431541

The FDA completed an inspection of Icahn School of Medicine at Mount Sinai IRB on March 25, 2026 in New York, NY. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
March 25, 2026
Fiscal Year
2026
Product Type
Biologics
Project Area
Bioresearch Monitoring
Location
New York, NY (United States)

Additional Details

IRB

Facility

Other inspections at this facility

  • 1047499 (NAI Thu Mar 22 2018 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 863841 (VAI Fri Jan 31 2014 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources